Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin Mundt

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
NPJ Precision Oncology|November 3, 2024
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testingTuya Pal, Erin Mundt, Marcy E Richardson, et al.
JAMA|September 29, 2018
Prevalence of Variant Reclassification Following Hereditary Cancer Genetic TestingJacqueline Mersch, Nichole Brown, Sara Pirzadeh-Miller, et al.
Frontiers in Oncology|February 16, 2023
Discordance between germline genetic findings and abnormal tumor immunohistochemistry staining of mismatch repair proteins in individuals with suspected Lynch syndromeShujuan Pan, Hannah Cox, Jamie Willmott, et al.
Journal of Community Genetics|January 5, 2017
Assessment of in silico protein sequence analysis in the clinical classification of variants in cancer risk genesIain D Kerr, Hannah C Cox, Kelsey Moyes, et al.
Familial Cancer|August 14, 2014
High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registryChristophe Rosty, Michael D Walsh, Noralane M Lindor, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
NPJ Precision Oncology|November 3, 2024
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testingTuya Pal, Erin Mundt, Marcy E Richardson, et al.
JAMA|September 29, 2018
Prevalence of Variant Reclassification Following Hereditary Cancer Genetic TestingJacqueline Mersch, Nichole Brown, Sara Pirzadeh-Miller, et al.
Frontiers in Oncology|February 16, 2023
Discordance between germline genetic findings and abnormal tumor immunohistochemistry staining of mismatch repair proteins in individuals with suspected Lynch syndromeShujuan Pan, Hannah Cox, Jamie Willmott, et al.
Journal of Community Genetics|January 5, 2017
Assessment of in silico protein sequence analysis in the clinical classification of variants in cancer risk genesIain D Kerr, Hannah C Cox, Kelsey Moyes, et al.
Familial Cancer|August 14, 2014
High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registryChristophe Rosty, Michael D Walsh, Noralane M Lindor, et al.
Pageof 2